Drugs / StrataMGT
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT06662942 Comparator | Oct 2024 → Oct 2025 overdue | vulvar lichen sclerosus | Andrew T. Goldstein, MD | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | StrataMGT | “StrataMGT® is a semi-permeable, non-resorbable and self-drying gel.” NCT06662942 ↗ |
| Route | Topical | “It will be applied topically to the vulvar skin.” NCT06662942 ↗ |